Aevi Genomic Medicine Inc. (GNMX) Slipped -6.53% or -0.01 To Price $0.19 On Monday


Aevi Genomic Medicine Inc. (GNMX) slipped -6.53% or -0.01 to $0.19. It is near to 312500 shares traded, which is 14.37% compare to the average total volume 2.17 million. The market cap of GNMX is $12.05 million. The year to date change is -80.69%. The 52 week price range is from $0.17 to $1.8. Price of GNMX have changed -5.19% during last week. It have changed -10.68% over last month, -8.72% over last 3 months, -81.40% over last 6 months and -88.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 0.22. It is 15.79% above current price. The 200-day Moving Averages for GNMX is 0.70. It is 268.42% above current price. The 52-week High is 1.8. It is 847.37% from the current price. The 52-week Low is 0.17. It is -10.53% from current price.

There are some statistics of GNMX. It is has market cap $12.05 million. The share outstanding is 64.77 million. The average volume is 2.17 million. The percent of top 15 Institution holding is 19.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -165.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -135.12%.


Tags:

Share this post